We’re pleased to share a new video interview featuring Rodica Bălașa exploring the role of cerebrospinal fluid (CSF) in the diagnosis of Multiple Sclerosis (MS). This presentation highlights how CSF analysis provides a diagnostic window into central nervous system disease processes, complementing clinical evaluation and imaging. Highlights of the interview include: The diagnostic value of CSF analysis in supporting MS diagnosis Using CSF to differentiate MS from other neurological conditions Insights into biomarkers and interpretive approaches in real-world clinical...

We’re pleased to share a new video interview featuring Gregor Brecl‑Jakob, in which he discusses the increasing recognition of optic nerve involvement as a core topographical feature in Multiple Sclerosis (MS). In this video, Brecl‑Jakob explains why formally acknowledging the optic nerve as a typical anatomical site enhances diagnostic sensitivity and better reflects disease dissemination observed in clinical practice, supporting neurologists in earlier and more confident diagnosis. Highlights of the interview include: The importance of considering the optic nerve as a formally...

We’re pleased to share a new expert video featuring Florian Deisenhammer on the topic of astrocytes and myelin – pathology and pathway. In this presentation, Deisenhammer explains how accurate differentiation between Multiple Sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and MOG antibody‑associated disease (MOGAD) depends on targeted testing and interpretation, even when clinical features overlap. Highlights of the keynote include: How antibody testing (AQP4‑IgG and MOG‑IgG) and biomarkers help distinguish MS from NMOSD and MOGAD The significance of distinct...

We’re proud to share a recent publication authored by ParadigMS experts, now featured in the European Journal of Neurology:“Generics, biosimilars and follow‐on non‐biologic complex drugs for Multiple Sclerosis: A narrative review of the regulatory and clinical implications for European neurologists.” The review examines the growing presence of generics, biosimilars, and follow-on non-biologic complex drugs (NBCDs) in multiple sclerosis care, outlining the regulatory landscape and the practical implications for clinical practice in Europe. Highlights include: Clear distinctions...

We are proud to highlight the work of Professor Patrick Vermersch, ParadigMS Board Member and Director of the Graduate School for Biology and Health at the University of Lille.Throughout his career, Professor Vermersch has made outstanding contributions to the fields of Multiple Sclerosis (MS) and neurodegenerative disease research. From early studies on Tau proteins in Alzheimer’s and Parkinson’s disease to groundbreaking work in MS biomarkers and treatment strategies, his research has consistently pushed the boundaries of neurology. He played a leading role in establishing a...